Mario Gargiulo - 01 May 2023 Form 4 Insider Report for Catalent, Inc.

Role
SVP, Ops, Biologics Europe
Signature
/s/ Amy Fallone, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 May 2023
Net transactions value
-$33,805
Form type
4
Filing time
03 May 2023, 18:58:00 UTC
Previous filing
26 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTLT Common Stock Sale $33,805 -678 -11% $49.86 5,676 01 May 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Mario Gargiulo is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares sold by the reporting person through an automatic "sell-to-cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
F2 Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $49.71 to $50.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes restricted stock units.